STOCK TITAN

Scage Future Warrants (SCAGW) Financials

SCAGW NASDAQ
FY2025 annual
Revenue $11.1M +82.0% YoY
Net Income -$12.9M n/m YoY
EPS (Diluted) -$0.18 YoY not available
Free Cash Flow -$5.9M n/m YoY
Source SEC Filings Latest period FY2025, ended Jun 30, 2025 Reported Currency USD FYE June

Newest figures come from the filing for FY2025, filed Nov 12, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SCAGW SEC filings page.

Scage Future Warrants (SCAGW) reported $11.1M in revenue for fiscal year 2025, up 82.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings.

Rhea AI SCAGW FY2025

Revenue is scaling, but costs are scaling faster, leaving a cash-dependent business with worsening liquidity and negative equity.

From FY2024 to FY2025, revenue increased 82.0% while gross margin fell 15.2 percentage points, showing that added volume did not preserve unit economics. Cost of revenue rose 112.3% and SG&A rose 146.2%, so growth expanded the cost base faster than sales.

Balance-sheet leverage looks less extreme because liabilities fell to 103.6% of assets from 346.3%, yet equity remained negative; the improvement came mainly from asset growth rather than a positive capital cushion. Short-term flexibility weakened: the current ratio dropped from 0.7x to 0.2x as current assets fell while current liabilities doubled.

Operating cash flow remained an outflow of about $6M in FY2024 and FY2025 while net loss more than doubled, so accounting deterioration was not mirrored one-for-one in cash. FY2025 financing cash flow of $24.7M alongside investing cash flow of -$20.7M shows that major cash movements were funded through financing rather than operating generation.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

We do not publish a peer-relative financial health score for Scage Future Warrants, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.

Piotroski F-Score Partial
2/8

Scage Future Warrants passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality No Cash Backing
N/A

Scage Future Warrants reported a net loss of $12.9M while operations used $5.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Scage Future Warrants reported an operating loss of $13.4M against $338K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$11.1M
YoY+82.0%

Scage Future Warrants generated $11.1M in revenue in fiscal year 2025. This represents an increase of 82.0% from the prior year.

EBITDA
-$13.1M
YoYn/m

Scage Future Warrants's EBITDA was -$13.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. The change from the prior year is not meaningful, because that figure was zero or negative.

Net Income
-$12.9M
YoYn/m

Scage Future Warrants reported a net loss of $12.9M in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.

EPS (Diluted)
-$0.18

Scage Future Warrants earned -$0.18 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
-$5.9M
YoYn/m

Scage Future Warrants recorded an outflow of $5.9M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. The change from the prior year is not meaningful, because that figure was zero or negative.

Cash & Debt
$91K
YoY-95.4%

Scage Future Warrants held $91K in cash as of fiscal year 2025; no long-term debt figure is on record for that period.

Shares Outstanding
72M

Scage Future Warrants had 72M shares outstanding in fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
-6.4%
YoY-15.2pp

Scage Future Warrants's gross margin was -6.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 15.2 percentage points from the prior year.

Operating Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Return on Equity

Not reported for fiscal year 2025.

Capital Allocation

R&D Spending
$1.5M
YoY-9.0%

Scage Future Warrants invested $1.5M in research and development in fiscal year 2025. This represents a decrease of 9.0% from the prior year.

Capital Expenditures
$13K
YoY-73.7%

Scage Future Warrants invested $13K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 73.7% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

SCAGW Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SCAGW annual income statement
MetricFY25FilingFY24FilingFY23Filing
Revenue$11.1M+82.0%$6.1M+1295.3%$438K
Cost of Revenue$11.8M+112.3%$5.6M+601.0%$795K
Gross Profit-$713K-232.9%$536Kn/m-$357K
R&D Expenses$1.5M-9.0%$1.7M-26.1%$2.3M
SG&A Expenses$11.1M+146.2%$4.5M+11.0%$4.1M
Operating Income-$13.4Mn/m-$5.9Mn/m-$6.7M
EBITDA-$13.1Mn/m-$5.3Mn/m-$6.3M
Interest Expense$338K-8.5%$370K+144.1%$151K
Net Income-$12.9Mn/m-$5.8Mn/m-$6.4M
EPS (Basic)-$0.18-$0.15n/m-$0.19
EPS (Diluted)-$0.18-$0.15n/m-$0.19
Diluted Shares (Avg)72M51M0.0%51M

Not reported in any period shown, so not listed: Income Tax.

SCAGW Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SCAGW annual balance sheet
MetricFY25FilingFY24FilingFY23Filing
Total Assets$26.5M+150.9%$10.6MN/A
Current Assets$5.0M-41.4%$8.6MN/A
Cash & Equivalents$91K-95.4%$2.0M+1045.0%$173K
Short-Term Investments$0n/m$0n/m$0
Inventory$1.0M-39.2%$1.7MN/A
Accounts Receivable$2.6M+28.7%$2.0MN/A
Long-Term Investments$20.3Mn/m$0n/m$0
Total Liabilities$27.4M-25.0%$36.6MN/A
Current Liabilities$25.4M+100.3%$12.7MN/A
Non-Current Liabilities$2.0M+2227.4%$87KN/A
Total Equity-$5.3Mn/m-$26.0MN/A
Retained Earnings-$40.2Mn/m-$27.3MN/A

Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.

SCAGW Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SCAGW annual cash flow statement
MetricFY25FilingFY24FilingFY23Filing
Operating Cash Flow-$5.9Mn/m-$6.2Mn/m-$4.9M
Depreciation & Amortization$301K-44.5%$542K+21.5%$446K
Stock-Based Compensation$1.8MN/AN/A
Capital Expenditures$13K-73.7%$51K-69.1%$166K
Free Cash Flow-$5.9Mn/m-$6.3Mn/m-$5.1M
Investing Cash Flow-$20.7Mn/m-$1.6Mn/m-$166K
Financing Cash Flow$24.7M+182.2%$8.7M+41.4%$6.2M

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

SCAGW Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SCAGW annual financial ratios
MetricFY25FilingFY24FilingFY23Filing
Gross Margin-6.4%-15.2pp8.8%+90.4pp-81.6%
Operating Margin-120.6%-96.1%-1534.2%
Net Margin-116.4%-95.1%-1469.8%
Return on Assets-48.9%+6.2pp-55.1%N/A
Current Ratio0.20-0.5x0.67N/A
Asset Turnover0.42-0.2x0.58N/A
FCF Margin-53.1%-102.7%-1155.1%

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity, Liabilities-to-Equity.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Note: Shareholder equity is negative (-$5.3M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.20), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

Scage Future Warrants (SCAGW) reported $11.1M in total revenue for fiscal year 2025. This represents a 82.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Scage Future Warrants (SCAGW) revenue grew by 82.0% year-over-year, from $6.1M to $11.1M in fiscal year 2025.

No, Scage Future Warrants (SCAGW) reported a net loss of $12.9M in fiscal year 2025.

Scage Future Warrants (SCAGW) reported diluted earnings per share of -$0.18 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Scage Future Warrants (SCAGW) had EBITDA of -$13.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Scage Future Warrants (SCAGW) had a gross margin of -6.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Scage Future Warrants (SCAGW) recorded an outflow of $5.9M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Scage Future Warrants (SCAGW) recorded an outflow of $5.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Scage Future Warrants (SCAGW) had $26.5M in total assets as of fiscal year 2025, including both current and long-term assets.

Scage Future Warrants (SCAGW) invested $13K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Scage Future Warrants (SCAGW) invested $1.5M in research and development during fiscal year 2025.

Scage Future Warrants (SCAGW) had 72M shares outstanding as of fiscal year 2025.

Scage Future Warrants (SCAGW) had a current ratio of 0.20 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Scage Future Warrants (SCAGW) had a return on assets of -48.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Scage Future Warrants (SCAGW) has negative shareholder equity of -$5.3M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Scage Future Warrants (SCAGW) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Scage Future Warrants (SCAGW) reported a net loss of $12.9M while operations used $5.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Scage Future Warrants (SCAGW) reported an operating loss of $13.4M against $338K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top